(1->4)-beta-D-glucan multiple interactions ISO RGD:731966 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of FABP5 mRNA CTD PMID:36331819 1,2-dichloroethane decreases expression ISO RGD:731966 6480464 ethylene dichloride results in decreased expression of FABP5 mRNA CTD PMID:28960355 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of FABP5 mRNA CTD PMID:30723492 17alpha-ethynylestradiol increases expression ISO RGD:731966 6480464 Ethinyl Estradiol results in increased expression of FABP5 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of FABP5 mRNA CTD PMID:15576828 , PMID:16174780 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of FABP5 mRNA CTD PMID:17351261 17alpha-ethynylestradiol multiple interactions ISO RGD:731966 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FABP5 mRNA CTD PMID:17942748 17beta-estradiol decreases expression ISO RGD:731966 6480464 Estradiol results in decreased expression of FABP5 mRNA CTD PMID:19484750 17beta-estradiol increases expression ISO RGD:736313 6480464 Estradiol results in increased expression of FABP5 mRNA CTD PMID:31614463 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of FABP5 mRNA CTD PMID:32145629 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:27291303 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:731966 6480464 2 more ... CTD PMID:30294300 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:736313 6480464 2 more ... CTD PMID:23146750 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:731966 6480464 Tetrachlorodibenzodioxin results in increased expression of FABP5 mRNA CTD PMID:15800033 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of FABP5 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:731966 6480464 Tetrachlorodibenzodioxin results in decreased expression of FABP5 mRNA CTD PMID:28238261 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:731966 6480464 Tetrachlorodibenzodioxin affects the expression of FABP5 mRNA CTD PMID:16611356 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of FABP5 mRNA CTD PMID:16054898 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of FABP5 mRNA CTD PMID:11752688 , PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:731966 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FABP5 mRNA CTD PMID:17942748 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:731966 6480464 2 more ... CTD PMID:18550172 2,4-dibromophenyl 2,4,5-tribromophenyl ether decreases expression ISO RGD:731966 6480464 2 more ... CTD PMID:18550172 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of FABP5 mRNA CTD PMID:21346803 2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-1,2,4-triazol-3-one increases expression ISO RGD:731966 6480464 Itraconazole results in increased expression of FABP5 mRNA CTD PMID:31099283 2-butoxyethanol increases expression ISO RGD:731966 6480464 n-butoxyethanol results in increased expression of FABP5 mRNA CTD PMID:19812364 2-hydroxypropanoic acid increases expression ISO RGD:736313 6480464 Lactic Acid results in increased expression of FABP5 mRNA CTD PMID:30851411 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:20959002 3,3',5-triiodo-L-thyronine increases expression EXP 6480464 Triiodothyronine results in increased expression of FABP5 mRNA CTD PMID:15953391 3,4-methylenedioxymethamphetamine increases expression ISO RGD:731966 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of FABP5 mRNA CTD PMID:20188158 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:731966 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FABP5 mRNA CTD PMID:23428407 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:736313 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of FABP5 mRNA CTD PMID:28628672 3H-1,2-dithiole-3-thione increases expression EXP 6480464 1, 2-dithiol-3-thione results in increased expression of FABP5 mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of FABP5 mRNA CTD PMID:30723492 4,4'-sulfonyldiphenol increases expression ISO RGD:736313 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of FABP5 mRNA CTD PMID:27685785 4,4'-sulfonyldiphenol multiple interactions ISO RGD:736313 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Fulvestrant] results in increased methylation of FABP5 gene CTD PMID:31601247 4,4'-sulfonyldiphenol decreases expression ISO RGD:731966 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of FABP5 mRNA CTD PMID:33297965 5-aza-2'-deoxycytidine multiple interactions ISO RGD:736313 6480464 [Decitabine affects the methylation of FABP5 promoter] which affects the expression of FABP5 protein CTD PMID:18636205 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of FABP5 mRNA CTD PMID:24780913 , PMID:30047161 9-cis-retinoic acid decreases expression ISO RGD:736313 6480464 Alitretinoin results in decreased expression of FABP5 mRNA CTD PMID:15982314 aflatoxin B1 decreases expression ISO RGD:731966 6480464 Aflatoxin B1 results in decreased expression of FABP5 mRNA CTD PMID:19770486 aflatoxin B1 increases expression ISO RGD:736313 6480464 Aflatoxin B1 results in increased expression of FABP5 mRNA CTD PMID:22100608 all-trans-4-oxoretinoic acid decreases expression ISO RGD:736313 6480464 4-oxoretinoic acid results in decreased expression of FABP5 mRNA CTD PMID:15982314 all-trans-retinoic acid increases expression ISO RGD:736313 6480464 Tretinoin metabolite results in increased expression of FABP5 mRNA CTD PMID:15982314 all-trans-retinoic acid decreases expression ISO RGD:736313 6480464 Tretinoin results in decreased expression of FABP5 mRNA CTD PMID:15982314 , PMID:23724009 amitrole increases expression EXP 6480464 Amitrole results in increased expression of FABP5 mRNA CTD PMID:30047161 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of FABP5 mRNA CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of FABP5 mRNA CTD PMID:30779732 antirheumatic drug increases expression ISO RGD:736313 6480464 Antirheumatic Agents results in increased expression of FABP5 mRNA CTD PMID:24449571 arsane multiple interactions ISO RGD:736313 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of FABP5 mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO RGD:736313 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of FABP5 mRNA CTD PMID:32525701 arsenite(3-) multiple interactions ISO RGD:736313 6480464 arsenite promotes the reaction [G3BP1 protein binds to FABP5 mRNA] CTD PMID:32406909 arsenous acid increases expression ISO RGD:736313 6480464 Arsenic Trioxide results in increased expression of FABP5 mRNA CTD PMID:22521957 benzo[a]pyrene decreases expression ISO RGD:736313 6480464 Benzo(a)pyrene results in decreased expression of FABP5 mRNA CTD PMID:20064835 benzo[a]pyrene increases methylation ISO RGD:736313 6480464 Benzo(a)pyrene results in increased methylation of FABP5 promoter CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO RGD:736313 6480464 Benzo(a)pyrene results in decreased methylation of FABP5 exon CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:731966 6480464 Benzo(a)pyrene results in decreased expression of FABP5 mRNA CTD PMID:19770486 benzo[b]fluoranthene increases expression ISO RGD:731966 6480464 benzo(b)fluoranthene results in increased expression of FABP5 mRNA CTD PMID:26377693 Benzo[k]fluoranthene increases expression ISO RGD:731966 6480464 benzo(k)fluoranthene results in increased expression of FABP5 mRNA CTD PMID:26377693 beta-hexachlorocyclohexane increases expression ISO RGD:731966 6480464 beta-hexachlorocyclohexane results in increased expression of FABP5 mRNA CTD PMID:28392238 bis(2-chloroethyl) sulfide decreases expression ISO RGD:736313 6480464 Mustard Gas results in decreased expression of FABP5 mRNA CTD PMID:25102026 bis(2-ethylhexyl) phthalate increases expression ISO RGD:731966 6480464 Diethylhexyl Phthalate results in increased expression of FABP5 mRNA CTD PMID:19850644 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FABP5 mRNA CTD PMID:31199487 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:731966 6480464 Diethylhexyl Phthalate results in decreased expression of FABP5 mRNA CTD PMID:28085963 bis(2-ethylhexyl) phthalate increases expression ISO RGD:736313 6480464 Diethylhexyl Phthalate results in increased expression of FABP5 mRNA CTD PMID:28412506 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:731966 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of FABP5 mRNA] CTD PMID:19850644 bisphenol A decreases expression ISO RGD:731966 6480464 bisphenol A results in decreased expression of FABP5 protein CTD PMID:24909818 bisphenol A decreases methylation ISO RGD:736313 6480464 bisphenol A results in decreased methylation of FABP5 gene CTD PMID:31601247 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FABP5 protein CTD PMID:32145629 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of FABP5 mRNA CTD PMID:30816183 , PMID:32145629 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of FABP5 mRNA CTD PMID:30903817 bisphenol A affects expression ISO RGD:736313 6480464 bisphenol A affects the expression of FABP5 mRNA CTD PMID:30903817 bisphenol A decreases expression ISO RGD:736313 6480464 bisphenol A results in decreased expression of FABP5 mRNA CTD PMID:29275510 bisphenol A increases expression ISO RGD:731966 6480464 bisphenol A results in increased expression of FABP5 protein CTD PMID:24909818 Brodifacoum decreases expression EXP 6480464 bromfenacoum results in decreased expression of FABP5 protein CTD PMID:28903499 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of FABP5 mRNA CTD PMID:24136188 butanal increases expression ISO RGD:736313 6480464 butyraldehyde results in increased expression of FABP5 mRNA CTD PMID:26079696 Butylbenzyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FABP5 mRNA CTD PMID:31199487 cadmium atom increases expression EXP 6480464 Cadmium results in increased expression of FABP5 mRNA CTD PMID:17066326 cadmium atom decreases expression ISO RGD:736313 6480464 Cadmium results in decreased expression of FABP5 mRNA CTD PMID:31082426 cadmium atom multiple interactions ISO RGD:736313 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FABP5 protein CTD PMID:33040242 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of FABP5 mRNA CTD PMID:17066326 cadmium dichloride multiple interactions ISO RGD:736313 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FABP5 protein CTD PMID:33040242 calciol decreases expression ISO RGD:731966 6480464 Cholecalciferol results in decreased expression of FABP5 mRNA CTD PMID:16508948 capsaicin decreases expression ISO RGD:736313 6480464 Capsaicin results in decreased expression of FABP5 mRNA CTD PMID:18533110 carbon nanotube decreases expression ISO RGD:736313 6480464 Nanotubes, Carbon results in decreased expression of FABP5 mRNA CTD PMID:24389112 carbon nanotube increases expression ISO RGD:731966 6480464 Nanotubes, Carbon analog results in increased expression of FABP5 mRNA CTD PMID:25554681 carbon nanotube decreases expression ISO RGD:731966 6480464 Nanotubes more ... CTD PMID:25620056 carbon nanotube affects expression ISO RGD:731966 6480464 Nanotubes, Carbon affects the expression of FABP5 mRNA CTD PMID:25554681 carnosic acid decreases expression ISO RGD:731966 6480464 salvin results in decreased expression of FABP5 protein CTD PMID:35926579 CGP 52608 multiple interactions ISO RGD:736313 6480464 CGP 52608 promotes the reaction [RORA protein binds to FABP5 gene] CTD PMID:28238834 chloropicrin increases expression ISO RGD:736313 6480464 chloropicrin results in increased expression of FABP5 mRNA CTD PMID:26352163 , PMID:28476498 choline multiple interactions ISO RGD:731966 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of FABP5 mRNA CTD PMID:33549593 choline multiple interactions EXP 6480464 [Folic Acid deficiency co-treated with Methionine deficiency co-treated with Choline deficiency] results in increased expression of FABP5 protein CTD PMID:19566968 ciguatoxin CTX1B affects expression ISO RGD:731966 6480464 Ciguatoxins affects the expression of FABP5 mRNA CTD PMID:18353800 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of FABP5 mRNA CTD PMID:22023808 clofibrate multiple interactions ISO RGD:731966 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of FABP5 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of FABP5 mRNA] CTD PMID:17585979 clofibric acid affects expression EXP 6480464 Clofibric Acid affects the expression of FABP5 mRNA CTD PMID:17602206 cobalt dichloride decreases expression ISO RGD:736313 6480464 cobaltous chloride results in decreased expression of FABP5 mRNA CTD PMID:19376846 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of FABP5 mRNA, cobaltous chloride results in increased expression of FABP5 protein CTD PMID:24386269 copper atom decreases expression ISO RGD:731966 6480464 Copper results in decreased expression of FABP5 mRNA CTD PMID:17205981 copper atom multiple interactions ISO RGD:731966 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of FABP5 mRNA CTD PMID:15467011 copper(0) decreases expression ISO RGD:731966 6480464 Copper results in decreased expression of FABP5 mRNA CTD PMID:17205981 copper(0) multiple interactions ISO RGD:731966 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of FABP5 mRNA CTD PMID:15467011 copper(II) sulfate decreases expression ISO RGD:736313 6480464 Copper Sulfate results in decreased expression of FABP5 mRNA CTD PMID:19549813 coumestrol multiple interactions ISO RGD:736313 6480464 [Coumestrol co-treated with ESR1 protein] results in increased expression of FABP5 mRNA, ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of FABP5 mRNA] CTD PMID:18310284 cyanocob(III)alamin multiple interactions ISO RGD:731966 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of FABP5 mRNA CTD PMID:33549593 dexamethasone multiple interactions ISO RGD:731966 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FABP5 mRNA CTD PMID:23428407 dexamethasone decreases expression ISO RGD:731966 6480464 Dexamethasone results in decreased expression of FABP5 mRNA CTD PMID:35589016 dexamethasone multiple interactions ISO RGD:736313 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of FABP5 mRNA CTD PMID:28628672 dexamethasone increases expression ISO RGD:736313 6480464 Dexamethasone results in increased expression of FABP5 mRNA CTD PMID:25047013 diarsenic trioxide increases expression ISO RGD:736313 6480464 Arsenic Trioxide results in increased expression of FABP5 mRNA CTD PMID:22521957 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of FABP5 mRNA CTD PMID:17379624 dibutyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FABP5 mRNA CTD PMID:31199487 dichlorine multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in decreased expression of FABP5 mRNA CTD PMID:18636392 dichloroacetic acid decreases expression ISO RGD:731966 6480464 Dichloroacetic Acid results in decreased expression of FABP5 mRNA CTD PMID:28962523 diclofenac increases expression ISO RGD:731966 6480464 Diclofenac results in increased expression of FABP5 mRNA CTD PMID:26934552 diethyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FABP5 mRNA CTD PMID:31199487 diethylstilbestrol increases expression ISO RGD:731966 6480464 Diethylstilbestrol results in increased expression of FABP5 mRNA CTD PMID:15171707 difenoconazole decreases expression ISO RGD:731966 6480464 difenoconazole results in decreased expression of FABP5 mRNA CTD PMID:34425431 diisobutyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FABP5 mRNA CTD PMID:31199487 diisononyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FABP5 mRNA CTD PMID:31199487 dioxygen increases expression EXP 6480464 Oxygen results in increased expression of FABP5 mRNA CTD PMID:22911455 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate decreases expression ISO RGD:736313 6480464 Antimony Potassium Tartrate results in decreased expression of FABP5 mRNA CTD PMID:28713220 diuron increases expression EXP 6480464 Diuron results in increased expression of FABP5 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:736313 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin multiple interactions ISO RGD:731966 6480464 [[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of FABP5 mRNA CTD PMID:21040762 doxorubicin increases expression ISO RGD:736313 6480464 Doxorubicin results in increased expression of FABP5 mRNA CTD PMID:29803840 doxorubicin decreases expression ISO RGD:731966 6480464 Doxorubicin results in decreased expression of FABP5 mRNA CTD PMID:21040762 emodin decreases expression ISO RGD:731966 6480464 Emodin results in decreased expression of FABP5 mRNA CTD PMID:15612046 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of FABP5 mRNA CTD PMID:29391264 enzyme inhibitor multiple interactions ISO RGD:736313 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of FABP5 protein CTD PMID:23301498 epoxiconazole affects expression ISO RGD:731966 6480464 epoxiconazole affects the expression of FABP5 mRNA CTD PMID:35436446 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of FABP5 mRNA CTD PMID:17920746 ethanol decreases expression ISO RGD:731966 6480464 Ethanol results in decreased expression of FABP5 mRNA CTD PMID:19167417 ethyl methanesulfonate decreases expression ISO RGD:736313 6480464 Ethyl Methanesulfonate results in decreased expression of FABP5 mRNA CTD PMID:23649840 flutamide increases expression EXP 6480464 Flutamide results in increased expression of FABP5 mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:731966 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of FABP5 mRNA CTD PMID:33549593 folic acid multiple interactions EXP 6480464 [Folic Acid deficiency co-treated with Methionine deficiency co-treated with Choline deficiency] results in increased expression of FABP5 protein CTD PMID:19566968 fonofos increases methylation ISO RGD:736313 6480464 Fonofos results in increased methylation of FABP5 promoter CTD PMID:22847954 fulvestrant multiple interactions ISO RGD:736313 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Fulvestrant] results in increased methylation of FABP5 gene CTD PMID:31601247 furan increases expression EXP 6480464 furan results in increased expression of FABP5 mRNA CTD PMID:20124500 , PMID:25539665 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of FABP5 mRNA CTD PMID:33387578 glafenine increases expression EXP 6480464 Glafenine results in increased expression of FABP5 mRNA CTD PMID:24136188 glycine betaine multiple interactions ISO RGD:731966 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of FABP5 mRNA CTD PMID:33549593 graphene oxide decreases expression ISO RGD:731966 6480464 graphene oxide results in decreased expression of FABP5 mRNA CTD PMID:33227293 hydrogen peroxide affects expression ISO RGD:736313 6480464 Hydrogen Peroxide affects the expression of FABP5 mRNA CTD PMID:21179406 indometacin multiple interactions ISO RGD:736313 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of FABP5 mRNA CTD PMID:28628672 indometacin increases expression EXP 6480464 Indomethacin results in increased expression of FABP5 mRNA CTD PMID:36868495 inulin multiple interactions ISO RGD:731966 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of FABP5 mRNA CTD PMID:36331819 isoprenaline increases expression ISO RGD:731966 6480464 Isoproterenol results in increased expression of FABP5 mRNA CTD PMID:21335049 isotretinoin decreases expression ISO RGD:736313 6480464 Isotretinoin results in decreased expression of FABP5 mRNA CTD PMID:15982314 itraconazole increases expression ISO RGD:731966 6480464 Itraconazole results in increased expression of FABP5 mRNA CTD PMID:31099283 ivermectin decreases expression ISO RGD:736313 6480464 Ivermectin results in decreased expression of FABP5 protein CTD PMID:32959892 ketoconazole increases expression EXP 6480464 Ketoconazole results in increased expression of FABP5 mRNA CTD PMID:37077353 ketoconazole increases expression ISO RGD:731966 6480464 Ketoconazole results in increased expression of FABP5 mRNA CTD PMID:31099283 L-methionine multiple interactions ISO RGD:731966 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of FABP5 mRNA CTD PMID:33549593 L-methionine multiple interactions EXP 6480464 [Folic Acid deficiency co-treated with Methionine deficiency co-treated with Choline deficiency] results in increased expression of FABP5 protein CTD PMID:19566968 lead(0) affects binding ISO RGD:736313 6480464 FABP5 protein binds to Lead CTD PMID:23896426 lead(0) affects expression ISO RGD:736313 6480464 Lead affects the expression of FABP5 mRNA CTD PMID:28903495 melphalan increases expression ISO RGD:736313 6480464 Melphalan results in increased expression of FABP5 mRNA CTD PMID:22363485 mercury atom increases expression EXP 6480464 Mercury results in increased expression of FABP5 mRNA CTD PMID:12730625 mercury(0) increases expression EXP 6480464 Mercury results in increased expression of FABP5 mRNA CTD PMID:12730625 methcathinone increases expression ISO RGD:736313 6480464 monomethylpropion results in increased expression of FABP5 mRNA CTD PMID:22303338 methimazole increases expression EXP 6480464 Methimazole results in increased expression of FABP5 mRNA CTD PMID:30047161 methyl methanesulfonate decreases expression ISO RGD:736313 6480464 Methyl Methanesulfonate results in decreased expression of FABP5 mRNA CTD PMID:23649840 methylisothiazolinone increases expression ISO RGD:736313 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of FABP5 mRNA CTD PMID:31629900 methylmercury chloride increases expression ISO RGD:736313 6480464 methylmercuric chloride results in increased expression of FABP5 mRNA CTD PMID:28001369 microcystin RR decreases expression ISO RGD:736313 6480464 microcystin RR results in decreased expression of FABP5 protein CTD PMID:19111056 monosodium L-glutamate multiple interactions ISO RGD:731966 6480464 [Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of FABP5 mRNA CTD PMID:19001666 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of FABP5 mRNA CTD PMID:28801915 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of FABP5 mRNA CTD PMID:19638242 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of FABP5 mRNA CTD PMID:28943392 N-nitrosodiethylamine increases expression ISO RGD:731966 6480464 Diethylnitrosamine results in increased expression of FABP5 mRNA CTD PMID:24535843 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of FABP5 mRNA CTD PMID:24136188 nickel sulfate increases expression ISO RGD:736313 6480464 nickel sulfate results in increased expression of FABP5 mRNA CTD PMID:16780908 nickel sulfate decreases expression ISO RGD:736313 6480464 nickel sulfate results in decreased expression of FABP5 mRNA CTD PMID:18651567 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of FABP5 mRNA CTD PMID:24136188 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of FABP5 mRNA CTD PMID:33484710 ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of FABP5 mRNA CTD PMID:16251485 ozone multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in decreased expression of FABP5 mRNA CTD PMID:18636392 ozone multiple interactions ISO RGD:731966 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of FABP5 mRNA CTD PMID:34911549 paracetamol multiple interactions ISO RGD:731966 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of FABP5 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of FABP5 mRNA] CTD PMID:17585979 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of FABP5 mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:736313 6480464 Acetaminophen results in decreased expression of FABP5 mRNA CTD PMID:21420995 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of FABP5 protein CTD PMID:16538041 paraquat increases expression ISO RGD:731966 6480464 Paraquat results in increased expression of FABP5 mRNA CTD PMID:21371552 parathion increases methylation ISO RGD:736313 6480464 Parathion results in increased methylation of FABP5 promoter CTD PMID:22847954 perfluorobutyric acid increases expression ISO RGD:731966 6480464 perfluorobutyric acid results in increased expression of FABP5 mRNA CTD PMID:34474067 perfluorooctane-1-sulfonic acid affects expression EXP 6480464 perfluorooctane sulfonic acid affects the expression of FABP5 mRNA CTD PMID:19162173 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:731966 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of FABP5 mRNA, [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of FABP5 mRNA CTD PMID:36331819 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:731966 6480464 perfluorooctane sulfonic acid results in decreased expression of FABP5 protein CTD PMID:26178269 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of FABP5 mRNA CTD PMID:19162173 perfluorooctanoic acid decreases expression ISO RGD:736313 6480464 perfluorooctanoic acid results in decreased expression of FABP5 mRNA CTD PMID:36326898 phenacetin increases expression EXP 6480464 Phenacetin results in increased expression of FABP5 mRNA CTD PMID:17698508 phenformin decreases expression EXP 6480464 Phenformin results in decreased expression of FABP5 mRNA CTD PMID:31324951 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of FABP5 mRNA CTD PMID:19162173 phenobarbital decreases expression ISO RGD:731966 6480464 Phenobarbital results in decreased expression of FABP5 mRNA CTD PMID:23091169 phenylhydrazine increases expression EXP 6480464 phenylhydrazine results in increased expression of FABP5 mRNA CTD PMID:17698508 piperonyl butoxide decreases expression EXP 6480464 Piperonyl Butoxide results in decreased expression of FABP5 mRNA CTD PMID:22484513 pirinixic acid increases expression ISO RGD:731966 6480464 pirinixic acid results in increased expression of FABP5 mRNA CTD PMID:18301758 pirinixic acid decreases expression ISO RGD:731966 6480464 pirinixic acid results in decreased expression of FABP5 mRNA CTD PMID:16985257 more ... pravastatin increases expression ISO RGD:731966 6480464 Pravastatin results in increased expression of FABP5 mRNA CTD PMID:27225895 pravastatin increases expression EXP 6480464 Pravastatin results in increased expression of FABP5 mRNA CTD PMID:27225895 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of FABP5 mRNA CTD PMID:19162173 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:731966 6480464 Pregnenolone Carbonitrile results in increased expression of FABP5 mRNA CTD PMID:28903501 progesterone decreases expression ISO RGD:731966 6480464 Progesterone results in decreased expression of FABP5 mRNA CTD PMID:19693291 propiconazole decreases expression ISO RGD:731966 6480464 propiconazole results in decreased expression of FABP5 mRNA CTD PMID:16730040 , PMID:21278054 protein kinase inhibitor multiple interactions ISO RGD:736313 6480464 Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of FABP5 mRNA] CTD PMID:28003376 quercetin multiple interactions ISO RGD:731966 6480464 [Dietary Fats co-treated with Quercetin] affects the expression of FABP5 mRNA CTD PMID:25047408 quinolin-8-ol decreases expression ISO RGD:731966 6480464 Oxyquinoline results in decreased expression of FABP5 mRNA CTD PMID:15612046 rac-lactic acid increases expression ISO RGD:736313 6480464 Lactic Acid results in increased expression of FABP5 mRNA CTD PMID:30851411 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of FABP5 mRNA CTD PMID:28374803 sarin decreases expression EXP 6480464 Sarin results in decreased expression of FABP5 protein CTD PMID:28973502 SB 431542 multiple interactions ISO RGD:736313 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO RGD:736313 6480464 Silicon Dioxide analog results in increased expression of FABP5 mRNA CTD PMID:25895662 silicon dioxide increases expression ISO RGD:731966 6480464 Silicon Dioxide results in increased expression of FABP5 mRNA CTD PMID:29203145 , PMID:29341224 sodium arsenate decreases expression ISO RGD:736313 6480464 sodium arsenate results in decreased expression of FABP5 mRNA CTD PMID:12727804 sodium arsenate multiple interactions ISO RGD:736313 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of FABP5 mRNA CTD PMID:32525701 sodium arsenite decreases expression ISO RGD:736313 6480464 sodium arsenite results in decreased expression of FABP5 mRNA, sodium arsenite results in decreased expression of FABP5 protein CTD PMID:19294697 , PMID:28713220 sodium arsenite affects expression ISO RGD:736313 6480464 sodium arsenite affects the expression of FABP5 mRNA CTD PMID:34032870 sodium arsenite increases expression ISO RGD:731966 6480464 sodium arsenite results in increased expression of FABP5 mRNA CTD PMID:31532247 sodium arsenite increases expression ISO RGD:736313 6480464 sodium arsenite results in increased expression of FABP5 mRNA CTD PMID:28595984 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of FABP5 mRNA CTD PMID:22561333 sodium dichromate increases expression ISO RGD:731966 6480464 sodium bichromate results in increased expression of FABP5 mRNA CTD PMID:31558096 Soman increases expression EXP 6480464 Soman results in increased expression of FABP5 mRNA CTD PMID:19281266 sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of FABP5 mRNA CTD PMID:30047161 sunitinib decreases expression ISO RGD:736313 6480464 Sunitinib results in decreased expression of FABP5 mRNA CTD PMID:31533062 terbufos increases methylation ISO RGD:736313 6480464 terbufos results in increased methylation of FABP5 promoter CTD PMID:22847954 testosterone decreases expression ISO RGD:731966 6480464 Testosterone results in decreased expression of FABP5 mRNA CTD PMID:19693291 testosterone increases expression ISO RGD:731966 6480464 Testosterone deficiency results in increased expression of FABP5 mRNA CTD PMID:33848595 testosterone multiple interactions ISO RGD:731966 6480464 1 more ... CTD PMID:33848595 thalidomide decreases expression ISO RGD:731966 6480464 Thalidomide results in decreased expression of FABP5 mRNA CTD PMID:26217789 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of FABP5 mRNA CTD PMID:28943392 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of FABP5 mRNA CTD PMID:34492290 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of FABP5 mRNA CTD PMID:30012374 toluene decreases expression EXP 6480464 Toluene results in decreased expression of FABP5 mRNA CTD PMID:22967744 tributylstannane increases expression ISO RGD:731966 6480464 tributyltin results in increased expression of FABP5 mRNA CTD PMID:23428407 , PMID:31939706 trichostatin A increases expression ISO RGD:736313 6480464 trichostatin A results in increased expression of FABP5 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:736313 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FABP5 mRNA CTD PMID:27188386 triphenyl phosphate increases expression ISO RGD:736313 6480464 triphenyl phosphate results in increased expression of FABP5 mRNA CTD PMID:28934090 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of FABP5 mRNA CTD PMID:30589522 Triptolide decreases expression ISO RGD:731966 6480464 triptolide results in decreased expression of FABP5 mRNA CTD PMID:32835833 troglitazone increases expression ISO RGD:731966 6480464 troglitazone results in increased expression of FABP5 mRNA CTD PMID:12732648 , PMID:28973697 tungsten increases expression ISO RGD:731966 6480464 Tungsten results in increased expression of FABP5 mRNA CTD PMID:30912803 urethane decreases expression ISO RGD:736313 6480464 Urethane results in decreased expression of FABP5 mRNA CTD PMID:28818685 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of FABP5 mRNA CTD PMID:24136188 valproic acid decreases methylation ISO RGD:736313 6480464 Valproic Acid results in decreased methylation of FABP5 gene CTD PMID:29154799 valproic acid multiple interactions ISO RGD:736313 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FABP5 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:736313 6480464 Valproic Acid results in increased expression of FABP5 mRNA CTD PMID:23179753 more ... vorinostat multiple interactions ISO RGD:736313 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FABP5 mRNA CTD PMID:27188386 zaragozic acid A increases expression ISO RGD:731966 6480464 squalestatin 1 results in increased expression of FABP5 mRNA CTD PMID:27225895 zaragozic acid A increases expression EXP 6480464 squalestatin 1 results in increased expression of FABP5 mRNA CTD PMID:27225895 zinc atom decreases expression ISO RGD:736313 6480464 Zinc results in decreased expression of FABP5 mRNA CTD PMID:15226459 zinc atom multiple interactions ISO RGD:731966 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of FABP5 mRNA CTD PMID:33549593 zinc sulfate decreases expression ISO RGD:736313 6480464 Zinc Sulfate results in decreased expression of FABP5 mRNA CTD PMID:15226459 zinc(0) decreases expression ISO RGD:736313 6480464 Zinc results in decreased expression of FABP5 mRNA CTD PMID:15226459 zinc(0) multiple interactions ISO RGD:731966 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of FABP5 mRNA CTD PMID:33549593
